La nuove prospettive della Medicina di Genere in Ginecologia.

/in /da

Autore: Francesco Libero Giorgino
Presidente A.G.E.O., Presidente F.I.O.G

La nuove prospettive della Medicina di Genere in Ginecologia.

Potrebbero interessarti
Il compartimento microbiologico urogenitale femminile con focus sul Lactobacillus paracasei subsp. paracasei F19
Prevention of fungal vaginitis / bacterial vaginosis comparing two new devices: tampons releasing a LN® probiotic mix and tampons releasing chlorhexidine vs. neutral tampons (placebo). Open preliminary randomized prospective clinical trial
La lattoferrina per os, un’importante alternativa priva di effetti indesiderati, nella prevenzione e trattamento dell ’ipoferremia ed anemia da carenza di ferro in gravidanza
Synbiotic Modulation of Gut Flora Effects on Minimal Hepatic Encephalopathy in Patients With Cirrhosi
Dietary Lactoferrin Alleviates Age-Related Lacrimal Gland Dysfunction in Mice
Evaluation of the Bacterial Vaginal Flora of 20 Postmenopausal Women by Direct (Nugent Score) and Molecular (Polymerase Chain Reaction and Denaturing Gradient Gel Electrophoresis) Techniques
Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in conjunction with use of a vaginal tampon containing LN® probiotic mixture (L. gasseri LN40, L. fermentum LN99, L. casei subsp. rhamnosus LN113) in the treatment of vaginosis
Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.